Related Experiment Video
Updated: May 5, 2026

Monitoring Astrocyte Reactivity and Proliferation in Vitro Under Ischemic-Like Conditions
Published on: October 21, 2017
Serum gamma-glutamyl transferase level as a risk factor in acute stroke
Quazi M Ismail1, Manoj K Prasad1, Sujeet Marandi1
1Department of Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.
Insights
Elevated serum gamma-glutamyl transferase (GGT) levels are independently associated with stroke risk, even in individuals without a history of alcohol consumption. This finding highlights GGT as a potential biomarker for stroke, independent of traditional risk factors.
Area of Science:
- Neurology
- Biochemistry
- Epidemiology
Background:
- Stroke is a leading cause of mortality and disability globally, particularly in low- and middle-income nations.
- Alcohol consumption is a known risk factor for stroke, with gamma-glutamyl transferase (GGT) serving as a marker for excessive intake.
- The role of GGT as an independent stroke risk factor in non-drinkers remains unclear.
Purpose of the Study:
- To investigate whether serum GGT levels are an independent risk factor for stroke in patients without a history of alcohol intake.
- To compare GGT levels between stroke patients and healthy controls.
Main Methods:
- An analytical cross-sectional comparative hospital-based study was conducted with 100 stroke patients and 100 age-sex-matched healthy controls.
- Serum GGT levels were measured and analyzed using SPSS and R studio software.
- Patients with a history of alcohol intake were excluded.
Main Results:
- Serum GGT levels were significantly higher in stroke patients (mean 58.30 U/L) compared to healthy controls (mean 17.48 U/L) (P < 0.001).
- Elevated GGT levels were observed in older age groups (60-80 years) compared to younger groups (40-60 years) (P < 0.01).
- Serum GGT levels were higher in stroke patients with hypertension, dyslipidemia, and ischemic stroke.
Conclusions:
- Serum GGT level is an independent risk factor for stroke, even when other risk factors like diabetes, hypertension, and dyslipidemia are present.
- While serum GGT levels correlate with stroke, they cannot predict patient outcomes (survival or death).
- GGT may serve as a valuable biomarker for identifying individuals at increased risk of stroke, irrespective of alcohol consumption.
Background:
Worldwide stroke is the second major cause of mortality and the fourth prominent cause of disease load after coronary heart disease and all types of malignancy. Greater than 3/4th of these cases are in low-priced and middle-priced nations. Several epidemiological studies have shown that alcohol consumption is a risk factor for stroke. The correlation between alcohol consumption and stroke involves various processes. For excessive alcohol consumption, GGT (gamma glutamyl transferase) is used as a marker. The study aims to see whether serum GGT level is an independent risk factor for stroke in young and elderly patients who do not have a history of alcohol intake.
Material And Method:
The study is an analytical cross-sectional comparative hospital-based study done in the Department of Medicine, RIMS, Ranchi from November 2019 to April 2021. A total number of 100 cases including both sexes who presented with the first episode of stroke have been compared with 100 age-sex-matched healthy control subjects without any cerebrovascular or cardiovascular disease meeting inclusion and exclusion criteria. Analysis of data is done by SPSS software and R studio software.
Result:
Serum GGT is lower in the age group of 40-60 years (24-hour GGT mean 50.70 U/L+SD 16.86) than the age group of 60-80 years (24-hour GGT 65.89 U/L+SD59.04) with a P value of 0.005. This is also true in 48-hour GGT (48.02 U/L+SD16.02) in 40-60 years compared to 57.94 U/L+SD42.81 in 60-80 years with a P value of 0.001 and 72-hour GGT (44.80 U/L+SD16.98) in 40-60 years compared to the mean (56.16 U/L+SD43.82) in 60-80 years with a P value of 0.001. This suggests that serum GGT level is significantly lower in the 40-60 years age group with a P value < 0.01. The serum GGT level in the case population is mean 58.30 (U/L) + SD43.87, and that in the control group is mean 17.48 (U/L) + SD4.32 with P value < 0.001. This implies an increased level of serum GGT level in stroke patients.
Conclusion:
Serum GGT level is independently correlated with stroke even in the presence of other risk factors for stroke such as diabetes mellitus, hypertension, and dyslipidemia. Serum GGT level is more in hypertensive, dyslipidemic, and ischemic stroke patients than in non-hypertensive, non-dyslipidemic, non-ischemic stroke patients, but serum GGT level cannot predict the outcome (survival or death) in stroke patients.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

